BAM
AVNS

Blueshift Asset Management’s Avanos Medical AVNS Stock Holding History

Blueshift Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,207
Closed -$490K – 912
2021
Q1 		$490K Buy
+11,207
New +$526K 0.05% 475
2020
Q1 		– Sell
-12,175
Closed -$410K – 208
2019
Q4 		$410K Buy
+12,175
New +$441K 0.05% 506
2019
Q3 		– Sell
-7,895
Closed -$344K – 720
2019
Q2 		$344K Buy
+7,895
New +$338K 0.05% 498

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Blueshift Asset Management's AVNS Position: Q2 2021 in Review

Blueshift Asset Management sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 11,207 shares — an estimated $490K sold.

Blueshift Asset Management first reported a position in AVNS in Q2 2019 and held it in 3 quarters. The position peaked at $490K in Q1 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • Blueshift Asset Management reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 11,207 Avanos Medical shares in Q2 2021, an estimated $490K.
  • Blueshift Asset Management first reported a position in Avanos Medical in Q2 2019 and held it in 3 quarters.
  • Blueshift Asset Management's Avanos Medical position peaked at $490K in Q1 2021.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Blueshift Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.